BIO-key Q3'26 net loss narrows 8% year over year to $886,083

• BIO-key’s Q3'26 loss per share more than doubled year over year to $4.01, including a $4.5 million noncash deemed dividend.
• Net loss narrowed 8% year over year to $886,083, excluding the deemed dividend related to the August warrant inducement.
• Total revenue fell year over year to $1.48 million, while license fee revenue climbed 39% to $1.28 million.
• Gross margin rose to 90% from 77% a year earlier, reflecting a higher proportion of high-margin license fees.
• Three government customers added in October brought new Middle East customers to eight over seven months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611130759PRIMZONEFULLFEED9877049) on November 13, 2026, and is solely responsible for the information contained therein.